- Home
- TERN vs EVM Comparison
TERN vs EVM Comparison
Compare TERN & EVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TERN
- EVM
- Stock Information
- Founded
- TERN 2017
- EVM 2002
- Country
- TERN United States
- EVM United States
- Employees
- TERN N/A
- EVM N/A
- Industry
- TERN Biotechnology: Pharmaceutical Preparations
- EVM Finance/Investors Services
- Sector
- TERN Health Care
- EVM Finance
- Exchange
- TERN Nasdaq
- EVM Nasdaq
- Market Cap
- TERN 262.9M
- EVM 217.4M
- IPO Year
- TERN 2021
- EVM N/A
- Fundamental
- Price
- TERN $3.54
- EVM $8.81
- Analyst Decision
- TERN Buy
- EVM
- Analyst Count
- TERN 5
- EVM 0
- Target Price
- TERN $15.63
- EVM N/A
- AVG Volume (30 Days)
- TERN 692.5K
- EVM 55.8K
- Earning Date
- TERN 05-08-2025
- EVM 01-01-0001
- Dividend Yield
- TERN N/A
- EVM 4.01%
- EPS Growth
- TERN N/A
- EVM N/A
- EPS
- TERN N/A
- EVM 0.20
- Revenue
- TERN N/A
- EVM N/A
- Revenue This Year
- TERN N/A
- EVM N/A
- Revenue Next Year
- TERN N/A
- EVM N/A
- P/E Ratio
- TERN N/A
- EVM $47.61
- Revenue Growth
- TERN N/A
- EVM N/A
- 52 Week Low
- TERN $1.87
- EVM $7.67
- 52 Week High
- TERN $11.40
- EVM $9.59
- Technical
- Relative Strength Index (RSI)
- TERN 67.52
- EVM 40.81
- Support Level
- TERN $3.01
- EVM $8.71
- Resistance Level
- TERN $3.60
- EVM $8.88
- Average True Range (ATR)
- TERN 0.21
- EVM 0.09
- MACD
- TERN 0.06
- EVM -0.00
- Stochastic Oscillator
- TERN 91.33
- EVM 27.78
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.
About EVM Eaton Vance California Municipal Bond Fund of Beneficial Interest $.01 par value
Eaton Vance California Municipal Bond Fund is an investment company with an objective to provide current income exempt from regular federal income tax, including alternative minimum tax, and, in state specific funds, taxes in its specified state. The company provides its solutions to individual investors, institutional investors, high net worth individuals, family office investors, and financial professionals. It offers a range of equity, income, and alternative strategies to institutional investors, both in the United States and internationally.